Company
Management
Christophe Thurieau
Chief Executive Officer
Executive Director of Research Institute and Global Head of External Research at Servier- In his rol… Read moree at Servier , Dr Christophe Thurieau is leading Servier’s Research centers and as head of external Research he is responsible for World Wide Research hubs to establish external strategic partnerships in R&D. Before joining Servier in April 2017 Dr Christophe Thurieau worked at Ipsen from 1996 to 2017. After different increasing roles and responsibilities within Research and Development at Ipsen, he was since 2009 President Ipsen Innovation and Senior Vice –President Global Scientific Affairs at Ipsen. He has authored more than 30 original research articles in international peer-reviewed scientific journal and holds 25 patents. Dr Christophe Thurieau obtained pre and post-doctoral training at Harvard medical school, Boston (U.S.) and received his Ph.D. in biochemistry from University Pierre and Marie Curie, Paris VI in 1988.
Rikke Bolding Jensen, M.Sc, Ph.d,
Director, Head of CMC Biologics
Rikke Bolding Jensen, M.Sc, Ph.d, is a Danish national, born in 1969. She joined Symphogen in 2014.… Read more
Before joining Symphogen, Rikke Bolding Jensen served development and CMC project management positions in Nycomed/Takeda and Maxygen.
Before joining Symphogen, Rikke Bolding Jensen served development and CMC project management positions in Nycomed/Takeda and Maxygen.
Karin Garre, MD
General Manager, Head of Symphogen (Direktør)
Karin Garre, MD, is a Danish-national, born in 1957. Dr. Garre joined Symphogen in 2018 and was appo… Read moreinted Chief Operating Officer as of 2019. June 2020 she was appointed General Manager and Head of Symphogen A/S, the Servier Center of Excellence for Antibodies.
Before joining Symphogen, Karin Garre gathered extensive experience with drug development and with change management processes in different R&D functions. She has held senior and executive leadership positions in the international pharmaceutical pharma and biotech industries such as Novo Nordisk, AstraZeneca and Genmab as well as in the Danish health care sector.
Before joining Symphogen, Karin Garre gathered extensive experience with drug development and with change management processes in different R&D functions. She has held senior and executive leadership positions in the international pharmaceutical pharma and biotech industries such as Novo Nordisk, AstraZeneca and Genmab as well as in the Danish health care sector.
Lisbet Løschenkohl
SVP, Head of People & Facility
Lisbet Løschenkohl is a Danish national, born in 1967. She joined Symphogen in 2008 as Head of HR. … Read more
Before joining Symphogen, Lisbet Løschenkohl headed the HR and Facility function in Rheosciene and Center for Clinical and Basic Research.
Before joining Symphogen, Lisbet Løschenkohl headed the HR and Facility function in Rheosciene and Center for Clinical and Basic Research.
Claus Haase, PhD
SVP, Head of Biologic Drug Design
Claus Haase, PhD, is a Danish national, born in 1976.
He joined Symphogen in 2023 and has pr… Read moreeviously held leadership positions in Novo Nordisk A/S, Ferring Pharmaceuticals and LEO Pharma.
He joined Symphogen in 2023 and has pr… Read moreeviously held leadership positions in Novo Nordisk A/S, Ferring Pharmaceuticals and LEO Pharma.